Category: Infectious Diseases
Global Infectious Diseases
-
Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV, Others), By End Use (Hospitals, Clinics, Others), By Region, and By Competition
... Competition Global Infectious Disease Therapeutics Market was valued at USD 67.04 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.00% through 2029. The Global Infectious ... Read More
-
Chikungunya Fever Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Diagnosis (ELISA Based Assays, Serological Tests, Virological Tests), By Treatment (Allopathy, Homeopathy, Ayurveda, Others), By End User (Hospital & Clinics, Ambulatory Surgical care, Others) Region and Competition
... Ambulatory Surgical care, Others) Region and Competition Global Chikungunya Fever Market was valued at USD 463.23 million in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.38% ... Read More
-
Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP], Ventilator-associated Pneumonia [VAP]), By Type (Drugs, Preventive Vaccines, Oxygen Therapy), By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Region and Competition
... Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Region and Competition Global Pneumonia Therapeutics Market was valued at USD 2.21 billion in 2023 and is anticipated ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Silencing, Cell Replacement, Gene Augmentation, Others], By Vector [Non-Viral Vectors, Viral Vectors], By Gene Delivery Method [Ex vivo and In vivo], By Application [Oncological Diseases, Neuromuscular Diseases, Cardiovascular Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global gene therapy market ... Read More
-
Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033
... Market The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033. The key factors driving ... Read More
-
2024 Global Forecast for Hospital Acquired Infection Control Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, Vaccines), Distribution Channel - Global Forecast 2024-2030
... USD 1.96 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.58% to reach USD 3.27 billion by 2030. Global Bovine Respiratory Disease Treatment Market FPNV Positioning Matrix The ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Digital Respiratory Devices Market by Product (Sensors & Apps, Smart Inhalers & Nebulizers), Disease Indications (Asthma, COPD, Infectious Diseases), Distribution Channel, End-Use - Global Forecast 2024-2030
... USD 23.45 billion in 2023 and expected to reach USD 30.61 billion in 2024, at a CAGR 30.95% to reach USD 154.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Infectious Disease Therapeutics Market by Drug (Antibiotics, Antifungal Drugs, Antiparasitic Drugs), Route of Administration (Intravenous, Oral, Topical), Disease, Distribution Channel, End-User - Global Forecast 2024-2030
... 116.21 billion in 2023 and expected to reach USD 121.27 billion in 2024, at a CAGR 4.41% to reach USD 157.28 billion by 2030. Global Infectious Disease Therapeutics Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 6.23% to reach USD 2.28 billion by 2030. Global Pneumonia Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Global Nontuberculous Mycobacterial Infections Market 2024-2028
... mycobacterial infections market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Lipid Nanoparticle Manufacturing Market: Services and Technologies, 2023-2035 - Distribution by Type of Lipid Nanoparticle (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers), Type of Molecule Delivered (Nucleic Acids, Small Molecules, Proteins/Peptides and Others), Company Size (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts
... (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) ... Read More
-
ELISpot and FluoroSpot Assay Market by Product (Assay kit (Technique, Utility, Analyte (T Cell and B Cell assay)), Analyzer), Application (Transplants, Infectious Diseases, Vaccine Development, Cancer Research), End User - Global Forecast to 2028
... global ELISpot and FluoroSpot Assays Market is expected to reach USD 421 million by 2028 from USD 292 million in 2023, at a CAGR of 7.6% during the forecast period. Market is driven by factors ... Read More
-
Orphan Drugs Market Forecasts to 2030 – Global Analysis By Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious diseases and Neurological diseases), Drug Type (Non-Biologics and Biologics), Sale, Drug, Distribution Channel and By Geography
... By Geography According to Stratistics MRC, the Global Orphan Drugs Market is accounted for $175.8 billion in 2023 and is expected to reach $445.5 billion by 2030 growing at a CAGR of 14.2% during the ... Read More
-
Global Hospital Hygiene Management Market - Analysis and Forecast, 2022-2032
... ongoing COVID-19 pandemic. This report provides an in-depth analysis of the evolving landscape of hospital hygiene management, with a specific focus on new innovations in the industry. The three key areas of innovation discussed in ... Read More
-
Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030
... (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030 Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of ... Read More
-
2023 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. ... Read More
-
Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 15.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Hospital infection therapeutics refers to various pharmaceutical drugs used for the treatment of nosocomial infections. These infections can ... Read More
Research Assistance
